Category:
Active Pharmaceutical Ingredients
Dabrafenib (CAS 1195765-45-7) is a selective BRAF V600E inhibitor used in oncology. Its synthesis involves advanced organic coupling and purification processes. The molecular formula is C20H18ClN5O.
Contraindicated in patients with wild-type BRAF tumors. Requires storage below 25°C in dry conditions. Strict occupational safety protocols are mandatory due to cytotoxicity risks during handling.